RVL Pharmaceuticals plc
RVLPDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739426
RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding RVL Pharmaceuticals plc changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 35 | 31 | −4 |
| Shares | 4.03M | 17.3M | +13.3M (+329.2%) |
| Value | $11.9M | $18.7M | +$6.80M (+57.3%) |
New holders (8)
Institutions that held RVL Pharmaceuticals plc at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,148,832 | $8.80M | 3.14% |
| Alyeska Investment Group, L.P. | 1,125,689 | $1.22M | 0.01% |
| ArrowMark Colorado Holdings LLC | 1,000,000 | $1.08M | 0.01% |
| Two Sigma Investments, LP | 249,851 | $270.0K | 0.00% |
| Titleist Asset Management, Ltd. | 80,184 | $87.0K | 0.02% |
| Two Sigma Advisers, LP | 63,200 | $68.0K | 0.00% |
| Huntington National Bank | 1,650 | $2.00K | 0.00% |
| Simplex Trading, LLC | 2,298 | $2.00K | 0.00% |
Sold out (12)
Institutions that held RVL Pharmaceuticals plc at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Ergoteles LLC | 41,349 | $122.0K |
| Goldman Sachs Group Inc | 27,120 | $80.0K |
| HRT Financial LP | 22,866 | $67.0K |
| ProShare Advisors LLC | 13,434 | $40.0K |
| Nations Financial Group Inc, | 12,500 | $37.0K |
| Walleye Trading LLC | 10,000 | $30.0K |
| Citigroup Inc | 3,526 | $10.0K |
| Barclays PLC | 2,425 | $7.00K |
| O'Shaughnessy Asset Management, LLC | 1,299 | $4.00K |
| Penserra Capital Management LLC | 1,440 | $4.00K |
| BNP Paribas Arbitrage, SA | 43 | $127 |
| Daiwa Securities Group Inc. | 140 | $0 |